Literature DB >> 23987565

Factors associated with changes into public or private maternity care for a second pregnancy.

Jane B Ford1, Jason P Bentley, Jonathan M Morris, Christine L Roberts.   

Abstract

OBJECTIVE: The aim of this study was to determine whether outcomes in a first pregnancy were associated with changes into and out of public maternity care.
METHODS: The study population included 155492 women with first and second sequential singleton births, 2000-09 in New South Wales. Analyses were stratified by whether obstetric care for the first birth involved private or public maternity care. Interventions, infant and maternal outcomes were assessed as predictors of a change in care. Adjusted odds ratios for changing care were obtained from logistic regression using backwards elimination.
RESULTS: Similar proportions of women changed from private to public care between first and second births (9.6% compared with 9.4% public to private, P-value=0.10). Although interventions (operative delivery, epidural) and outcomes (low Apgar, preterm birth, perinatal death, postpartum haemorrhage, perineal tear and severe maternal morbidity) were all associated with changes from public to private care, only poor infant condition (adjusted odds ratio 1.39, 95% confidence interval 1.15-1.68) was associated with a change from private to public care.
CONCLUSIONS: The majority of women had consistent care type for both births. This may indicate that women are generally satisfied with care, they rationalise that their first birth care was optimal or they value continuity of carer across pregnancies.

Entities:  

Mesh:

Year:  2013        PMID: 23987565     DOI: 10.1071/AH12017

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  1 in total

1.  Outcomes of subsequent pregnancy following obstetric transfusion in a first birth.

Authors:  Jillian A Patterson; Tanya Nippita; Deborah A Randall; David O Irving; Jane B Ford
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.